Principal Financial Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
BC
B
WP
Principal Financial Group's ANAB Position: Q2 2023 in Review
Principal Financial Group sold out of AnaptysBio (ANAB) in Q2 2023, closing a stake of 10,663 shares — an estimated $232K sold.
Principal Financial Group first reported a position in ANAB in Q4 2017 and held it in 13 quarters. The position peaked at $754K in Q4 2021. 116 funds tracked by Wall St. Rank hold ANAB as of Q2 2023.
- Principal Financial Group reported no remaining AnaptysBio position as of Q2 2023 after selling out during the quarter.
- Principal Financial Group sold 10,663 AnaptysBio shares in Q2 2023, an estimated $232K.
- Principal Financial Group first reported a position in AnaptysBio in Q4 2017 and held it in 13 quarters.
- Principal Financial Group's AnaptysBio position peaked at $754K in Q4 2021.
- 116 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2023.
Based on Principal Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.